USD 142.33
(-1.04%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.13 Billion USD | -0.22% |
2022 | 2.13 Billion USD | -1.0% |
2021 | 2.15 Billion USD | 0.82% |
2020 | 2.13 Billion USD | 7.51% |
2019 | 1.98 Billion USD | 1.79% |
2018 | 1.95 Billion USD | 6.97% |
2017 | 1.82 Billion USD | 27.57% |
2016 | 1.43 Billion USD | 12.4% |
2015 | 1.27 Billion USD | -4.16% |
2014 | 1.32 Billion USD | 30.69% |
2013 | 1.01 Billion USD | 7.79% |
2012 | 943.91 Million USD | 8.66% |
2011 | 868.72 Million USD | 14.92% |
2010 | 755.92 Million USD | 8.34% |
2009 | 697.7 Million USD | -0.48% |
2008 | 701.08 Million USD | -11.52% |
2007 | 792.37 Million USD | 22.84% |
2006 | 645.04 Million USD | 18.74% |
2005 | 543.23 Million USD | 10.06% |
2004 | 493.59 Million USD | 3.95% |
2003 | 474.83 Million USD | 6.0% |
2002 | 447.97 Million USD | 1.58% |
2001 | 441.02 Million USD | -12.95% |
2000 | 506.64 Million USD | 15.44% |
1999 | 438.9 Million USD | 48.78% |
1998 | 295 Million USD | 23.59% |
1997 | 238.7 Million USD | 1.14% |
1996 | 236 Million USD | -4.03% |
1995 | 245.9 Million USD | 26.49% |
1994 | 194.4 Million USD | -10.41% |
1993 | 217 Million USD | 41.74% |
1992 | 153.1 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 2.07 Billion USD | 1.4% |
2024 Q2 | 2.04 Billion USD | -1.5% |
2024 Q1 | 2.07 Billion USD | -2.65% |
2023 Q1 | 2.17 Billion USD | 1.86% |
2023 Q2 | 2.15 Billion USD | -0.72% |
2023 Q3 | 2.08 Billion USD | -3.46% |
2023 Q4 | 2.13 Billion USD | 2.21% |
2023 FY | 2.13 Billion USD | -0.22% |
2022 Q3 | 2.13 Billion USD | -7.42% |
2022 FY | 2.13 Billion USD | -1.0% |
2022 Q4 | 2.13 Billion USD | -0.14% |
2022 Q1 | 2.4 Billion USD | 11.7% |
2022 Q2 | 2.3 Billion USD | -4.12% |
2021 Q1 | 2.09 Billion USD | -2.22% |
2021 Q4 | 2.15 Billion USD | 1.0% |
2021 Q3 | 2.13 Billion USD | 0.57% |
2021 Q2 | 2.12 Billion USD | 1.51% |
2021 FY | 2.15 Billion USD | 0.82% |
2020 Q4 | 2.13 Billion USD | 1.78% |
2020 Q1 | 2.18 Billion USD | 10.0% |
2020 Q2 | 2.16 Billion USD | -0.95% |
2020 Q3 | 2.1 Billion USD | -3.06% |
2020 FY | 2.13 Billion USD | 7.51% |
2019 Q2 | 2 Billion USD | 3.05% |
2019 Q1 | 1.94 Billion USD | -0.36% |
2019 Q4 | 1.98 Billion USD | 4.12% |
2019 Q3 | 1.91 Billion USD | -4.79% |
2019 FY | 1.98 Billion USD | 1.79% |
2018 FY | 1.95 Billion USD | 6.97% |
2018 Q1 | 1.87 Billion USD | 2.81% |
2018 Q4 | 1.95 Billion USD | -4.01% |
2018 Q3 | 2.03 Billion USD | 8.63% |
2018 Q2 | 1.87 Billion USD | -0.22% |
2017 FY | 1.82 Billion USD | 27.57% |
2017 Q4 | 1.82 Billion USD | -12.43% |
2017 Q1 | 1.28 Billion USD | -10.44% |
2017 Q3 | 2.08 Billion USD | 54.06% |
2017 Q2 | 1.35 Billion USD | 5.59% |
2016 FY | 1.43 Billion USD | 12.4% |
2016 Q2 | 1.38 Billion USD | -1.63% |
2016 Q3 | 1.39 Billion USD | 0.74% |
2016 Q4 | 1.43 Billion USD | 2.43% |
2016 Q1 | 1.41 Billion USD | 10.74% |
2015 FY | 1.27 Billion USD | -4.16% |
2015 Q4 | 1.27 Billion USD | -4.31% |
2015 Q1 | 1.3 Billion USD | -1.62% |
2015 Q2 | 1.35 Billion USD | 3.2% |
2015 Q3 | 1.33 Billion USD | -1.35% |
2014 Q1 | 1.06 Billion USD | 4.33% |
2014 Q3 | 1.08 Billion USD | -1.28% |
2014 Q4 | 1.32 Billion USD | 22.18% |
2014 FY | 1.32 Billion USD | 30.69% |
2014 Q2 | 1.1 Billion USD | 3.85% |
2013 Q1 | 964.8 Million USD | 2.21% |
2013 Q2 | 928.71 Million USD | -3.74% |
2013 Q4 | 1.01 Billion USD | 5.16% |
2013 FY | 1.01 Billion USD | 7.79% |
2013 Q3 | 967.52 Million USD | 4.18% |
2012 FY | 943.91 Million USD | 8.66% |
2012 Q3 | 879.03 Million USD | 9.97% |
2012 Q4 | 943.91 Million USD | 7.38% |
2012 Q2 | 799.32 Million USD | -6.37% |
2012 Q1 | 853.75 Million USD | -1.72% |
2011 Q1 | 814.18 Million USD | 8.13% |
2011 Q4 | 868.72 Million USD | 7.27% |
2011 FY | 868.72 Million USD | 14.92% |
2011 Q3 | 809.85 Million USD | 1.2% |
2011 Q2 | 800.24 Million USD | -1.71% |
2010 FY | 755.92 Million USD | 8.34% |
2010 Q2 | 664.62 Million USD | -9.28% |
2010 Q4 | 752.94 Million USD | 3.57% |
2010 Q3 | 727 Million USD | 9.39% |
2010 Q1 | 732.63 Million USD | 4.28% |
2009 FY | 697.7 Million USD | -0.48% |
2009 Q1 | 651.31 Million USD | -6.96% |
2009 Q3 | 680.5 Million USD | 2.14% |
2009 Q4 | 702.55 Million USD | 3.24% |
2009 Q2 | 666.27 Million USD | 2.3% |
2008 Q3 | 825.1 Million USD | -0.76% |
2008 Q4 | 700.02 Million USD | -15.16% |
2008 FY | 701.08 Million USD | -11.52% |
2008 Q1 | 855.44 Million USD | 7.96% |
2008 Q2 | 831.43 Million USD | -2.81% |
2007 Q3 | 779.13 Million USD | 6.91% |
2007 FY | 792.37 Million USD | 22.84% |
2007 Q4 | 792.37 Million USD | 1.7% |
2007 Q2 | 728.75 Million USD | 4.38% |
2007 Q1 | 698.2 Million USD | 8.24% |
2006 FY | 645.04 Million USD | 18.74% |
2006 Q1 | 577.43 Million USD | 6.3% |
2006 Q4 | 645.04 Million USD | -1.76% |
2006 Q2 | 601.92 Million USD | 4.24% |
2006 Q3 | 656.6 Million USD | 9.08% |
2005 FY | 543.23 Million USD | 10.06% |
2005 Q1 | 508.65 Million USD | 3.05% |
2005 Q2 | 502.98 Million USD | -1.12% |
2005 Q3 | 511.2 Million USD | 1.64% |
2005 Q4 | 543.23 Million USD | 6.26% |
2004 Q2 | 487.12 Million USD | 0.96% |
2004 FY | 493.59 Million USD | 3.95% |
2004 Q1 | 482.49 Million USD | 1.61% |
2004 Q4 | 493.59 Million USD | 4.86% |
2004 Q3 | 470.73 Million USD | -3.37% |
2003 Q4 | 474.83 Million USD | -1.64% |
2003 Q2 | 487.43 Million USD | 2.96% |
2003 Q1 | 473.43 Million USD | 5.68% |
2003 FY | 474.83 Million USD | 6.0% |
2003 Q3 | 482.76 Million USD | -0.96% |
2002 Q1 | 444.55 Million USD | 0.8% |
2002 Q2 | 459.33 Million USD | 3.33% |
2002 Q4 | 447.97 Million USD | -3.49% |
2002 Q3 | 464.15 Million USD | 1.05% |
2002 FY | 447.97 Million USD | 1.58% |
2001 Q3 | 465.31 Million USD | -1.67% |
2001 Q1 | 495.07 Million USD | -2.29% |
2001 FY | 441.02 Million USD | -12.95% |
2001 Q4 | 441.02 Million USD | -5.22% |
2001 Q2 | 473.23 Million USD | -4.41% |
2000 Q4 | 506.64 Million USD | 4.16% |
2000 Q2 | 481.98 Million USD | 2.33% |
2000 Q1 | 471.02 Million USD | 7.32% |
2000 FY | 506.64 Million USD | 15.44% |
2000 Q3 | 486.39 Million USD | 0.91% |
1999 Q4 | 438.9 Million USD | -1.77% |
1999 Q3 | 446.8 Million USD | 7.2% |
1999 Q2 | 416.8 Million USD | -2.23% |
1999 FY | 438.9 Million USD | 48.78% |
1999 Q1 | 426.3 Million USD | 44.51% |
1998 Q3 | 315.3 Million USD | 14.4% |
1998 Q2 | 275.6 Million USD | 4.63% |
1998 Q1 | 263.4 Million USD | 10.35% |
1998 Q4 | 295 Million USD | -6.44% |
1998 FY | 295 Million USD | 23.59% |
1997 Q3 | 249.7 Million USD | 2.71% |
1997 Q4 | 238.7 Million USD | -4.41% |
1997 Q2 | 243.1 Million USD | 1.67% |
1997 Q1 | 239.1 Million USD | 1.31% |
1997 FY | 238.7 Million USD | 1.14% |
1996 Q1 | 244.8 Million USD | -0.45% |
1996 FY | 236 Million USD | -4.03% |
1996 Q4 | 236 Million USD | -2.2% |
1996 Q3 | 241.3 Million USD | 0.29% |
1996 Q2 | 240.6 Million USD | -1.72% |
1995 FY | 245.9 Million USD | 26.49% |
1995 Q1 | 218.6 Million USD | 12.45% |
1995 Q2 | 225 Million USD | 2.93% |
1995 Q3 | 222.1 Million USD | -1.29% |
1995 Q4 | 245.9 Million USD | 10.72% |
1994 Q2 | 234.3 Million USD | -0.04% |
1994 FY | 194.4 Million USD | -10.41% |
1994 Q1 | 234.4 Million USD | 8.02% |
1994 Q4 | 194.4 Million USD | -19.2% |
1994 Q3 | 240.6 Million USD | 2.69% |
1993 Q4 | 217 Million USD | -9.77% |
1993 Q1 | 150 Million USD | -2.02% |
1993 FY | 217 Million USD | 41.74% |
1993 Q2 | 243.5 Million USD | 62.33% |
1993 Q3 | 240.5 Million USD | -1.23% |
1992 FY | 153.1 Million USD | 0.0% |
1992 Q4 | 153.1 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alcon Inc. | 8.98 Billion USD | 76.292% |
Baxter International Inc. | 19.8 Billion USD | 89.244% |
Becton, Dickinson and Company | 26.98 Billion USD | 92.104% |
Bausch + Lomb Corporation | 6.52 Billion USD | 67.332% |
Haemonetics Corporation | 1.23 Billion USD | -72.429% |
Envista Holdings Corp | 2.43 Billion USD | 12.365% |
ResMed Inc. | 2 Billion USD | -6.087% |
Teleflex Incorporated | 3.09 Billion USD | 31.084% |
Warby Parker Inc. | 278.52 Million USD | -664.955% |
West Pharmaceutical Services, Inc. | 948.5 Million USD | -124.628% |